Tags: Drug.

SRT2183 is a drug in development by Sirtris Pharmaceuticals intended as a small-molecule activator of the sirtuin subtype SIRT1. It has similar activity in animal studies to another SIRT1 activator SRT1720 but is closer in potency to resveratrol.

SRT2183_skeletal.svg
ATC prefix
None
IUPAC name
N-[2-(3-[(3R)-3-hydroxypyrrolidin-1-yl]methylimidazo[21-b][13]thiazol-6-yl)phenyl]naphthalene-2-carboxamide
PubChem
24180126

Loading...

This page contains content from the copyrighted Wikipedia article "SRT2183"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.